Cargando…
Worldwide Incidence of Colorectal Cancer, Leukemia, and Lymphoma in Inflammatory Bowel Disease: An Updated Systematic Review and Meta-Analysis
Background/Aims. Inflammatory bowel disease (IBD) is associated with an increased risk of colorectal cancer (CRC). In addition, there may be an association between leukemia and lymphoma and IBD. We conducted a systematic review and meta-analysis of the IBD literature to estimate the incidence of CRC...
Autores principales: | Wheat, Chelle L., Clark-Snustad, Kindra, Devine, Beth, Grembowski, David, Thornton, Timothy A., Ko, Cynthia W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4884856/ https://www.ncbi.nlm.nih.gov/pubmed/27293427 http://dx.doi.org/10.1155/2016/1632439 |
Ejemplares similares
-
Inflammatory Bowel Disease (IBD) pharmacotherapy and the risk of serious infection: a systematic review and network meta-analysis
por: Wheat, Chelle L., et al.
Publicado: (2017) -
Pustular Rash in Crohn's Patient on Ustekinumab Raises Concern for Drug-Induced Paradoxical Psoriasis
por: Barahimi, Mitra, et al.
Publicado: (2021) -
Case Series: Re-induction of Intravenous, Weight-Based Ustekinumab Is Well Tolerated in Patients With Moderate–Severe Crohn’s Disease
por: Lee, Scott David, et al.
Publicado: (2022) -
A Comprehensive Self-Management Intervention for Inflammatory Bowel Disease (CSM-IBD): Protocol for a Pilot Randomized Controlled Trial
por: Kamp, Kendra, et al.
Publicado: (2023) -
Colorectal cancer population screening programs worldwide in 2016: An update
por: Navarro, Mercedes, et al.
Publicado: (2017)